StreetAlpha
13F holdings · Q3 2026

Theleme Partners

London, X0 · files as Theleme Partners LLP
Know the moment Theleme Partners filesYou follow Theleme Partners An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1511881

Theleme Partners reported 10 stocks worth $2.6B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are MRNA (48.9%), META (10.9%) and AMZN (8.7%). Compared with Q2 2026, the fund opened new positions in MSFT, added to AMZN, EFX and HDB and trimmed MRNA and META.

Latest filing: what Theleme Partners did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
1 new3 added2 trimmed0 sold outBought about $247M · sold about $316M
New 1
Added 3
Trimmed 2
Sold out 0

None

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$2.6B+55.7% vs last quarter
Stocks held101 new · 0 sold out
Top 5 weight83.9%very concentrated
Turnover21%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MRNA
Moderna Inc
$1.3B48.9%6.7M−1.4M (−17%)8 of 8
2
META
Meta Platforms Inc
$287M10.9%395K−64K (−14%)6 of 8
3
AMZN
Amazon Com Inc
$227M8.7%913K+90K (+11%)8 of 8
4
UBER
Uber Technologies Inc
$219M8.3%3.2MNo change8 of 8
5
MSFT
Microsoft Corp
$185M7.1%362KNew position1 of 8
6
TRU
Transunion
$145M5.5%2.4MNo change8 of 8
7
EQIX
Equinix Inc
$107M4.1%106KNo change2 of 8
8
EFX
Equifax Inc
$84.6M3.2%616K+42K (+7%)8 of 8
9
HDB
Hdfc Bank Ltd
$67.8M2.6%3M+1.5M (+95%)5 of 8
10
SIFY
Sify Technologies Ltd
$17M0.7%1.3MNo change5 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 8 quarters
$1.5BQ4 '24
$1.3BQ1 '25
$1.6BQ2 '25
$1.6BQ3 '25
$1.5BQ4 '25
$1.5BQ1 '26
$1.7BQ2 '26
$2.6BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Theleme Partners 13F FAQ

What does Theleme Partners own?

Theleme Partners reported 10 stocks worth $2.6B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are MRNA (48.9%), META (10.9%) and AMZN (8.7%). The table above lists every position in the filing (the top 10 without an account).

What did Theleme Partners buy and sell in Q3 2026?

Compared with Q2 2026: 1 new positions, 3 added to, 2 trimmed and 0 sold out. New positions include MSFT.

When will Theleme Partners file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Theleme Partners's portfolio worth?

The Q3 2026 filing reports $2.6B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.